To hear about similar clinical trials, please enter your email below
Trial Title:
Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study)
NCT ID:
NCT05537701
Condition:
Non-small Cell Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Study type:
Observational [Patient Registry]
Overall status:
Active, not recruiting
Study design:
Time perspective:
Prospective
Summary:
The primary objective is to describe eosinophil infiltration in resected (early stage)
NSCLC.
Secondary objectives are:
- to investigate the correlation of T-Eos and B-Eos in the aforementioned patient
population;
- to investigate the correlation between T-Eos and overall & disease-free survival;
- to investigate the localization of T-Eos (periphery vs. center of the tumor
lesions).
Criteria for eligibility:
Study pop:
Patients with resected, early stage NSCLC between 01-01-2015 and 30-04-2022 with
available tumour tissue for analysis will be included.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Resected, early stage NSCLC between 01-01-2015 and 30-04-2022 with available tumour
tissue
Exclusion Criteria:
- Inclusion in a clinical study contraindicating enrollment in the present study
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
CHU de Liege
Address:
City:
Liège
Zip:
4000
Country:
Belgium
Start date:
October 3, 2022
Completion date:
March 31, 2027
Lead sponsor:
Agency:
Centre Hospitalier Universitaire de Liege
Agency class:
Other
Source:
Centre Hospitalier Universitaire de Liege
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05537701
